Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study: Notice of Retraction

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Notice of Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279117/
http://dx.doi.org/10.1097/MD.0000000000006039
_version_ 1782502719749095424
collection PubMed
description
format Online
Article
Text
id pubmed-5279117
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-52791172017-02-08 Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study: Notice of Retraction Medicine (Baltimore) Notice of Retraction Wolters Kluwer Health 2017-01-20 /pmc/articles/PMC5279117/ http://dx.doi.org/10.1097/MD.0000000000006039 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle Notice of Retraction
Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study: Notice of Retraction
title Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study: Notice of Retraction
title_full Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study: Notice of Retraction
title_fullStr Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study: Notice of Retraction
title_full_unstemmed Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study: Notice of Retraction
title_short Combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: An observational study: Notice of Retraction
title_sort combined inhaled corticosteroid and long-acting β2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with airflow limitation: an observational study: notice of retraction
topic Notice of Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279117/
http://dx.doi.org/10.1097/MD.0000000000006039

Ejemplares similares